Pyxa Solutions announced today that it has merged with Red Nucleus Enterprises, a portfolio company of Renovus Capital Partners, with the Pyxa principals retaining a significant interest in the combined company. The three key executives of Pyxa Solutions – Carol Rutkowski, Michael Swalina and Dalia El-Sherif – will continue to lead the Pyxa operations.
Founded in 2012 and based in Malvern, Pennsylvania, Pyxa Solutions provides Life Sciences companies a unique opportunity to obtain regulatory services from industry veterans who “grew up in Pharma.” Pyxa Solutions team is comprised of senior management consultants and subject matter experts who specialize in cross-functional delivery stemming from activities led by Regulatory Affairs. Pyxa’s services span the entire drug development lifecycle for both developed and emerging markets. Through the company’s unique team-based approach, Pyxa delivers superior, scalable and adaptable solutions for the management of R&D submissions, information, systems and operations.
Pyxa Solutions managing partners in a joint statement stated, “After bootstrapping the Pyxa operations for the last seven years and experiencing tremendous growth, we are all excited to become part of a larger organization that shares our cultural and professional values. We remain as committed to the success of the organization as we were on the date of our formation and look forward to our journey ahead.”
Ian Kelly, the CEO of Red Nucleus and Atif Gilani, a Founding Partner of Renovus Capital Partners, added, “We are thrilled to welcome Pyxa Solutions into the Red Nucleus family. We believe that the combination of Pyxa’s client centric delivery model, and the global reach and operational resources of RN will create a market leader in this critical and growing segment of Regulatory Affairs.”
About Pyxa Solutions
Pyxa Solutions is a specialized provider of cross-functional R&D services and solutions stemming from Regulatory Affairs. With deep industry expertise, its subject matter experts work hand-in-hand with their Life Science clients to strategically resolve global R&D challenges and mitigate compliance risk. From global experience in submissions, system implementation, information management, labeling and business transformation excellence, their solutions improve efficiency, streamline operations, and enhance productivity. The Pyxa team prides itself on a collaborative team approach that instills and reinforces industry best practices in every project delivered.
More information can be found at www.pyxasolutions.com.
About Red Nucleus Enterprises
Red Nucleus is premier provider of award-winning e-learning, digital content and performance solutions for the Life Sciences industry. From its offices in the US, UK, and India, Red Nucleus develops innovative solutions that engage and inspire client facing teams throughout their continuing education journey. With a science-first focus, its solutions are designed to boost the clinical knowledge base of end users. Red Nucleus works exclusively within Life Sciences and therefore its team intimately understands Pharma business model, products, processes and challenges. The Red Nucleus team consists of more than 125 full-time employees whose commitment to creativity, quality, and on-time delivery is unrivaled in the space.
More information can be found at www.rednucleus.com.
About Renovus Capital Partners
Founded in 2010, Renovus Capital Partners is a Wayne, PA based education, training and human capital focused private equity firm. Renovus is based outside of Philadelphia and manages over $500 million of committed capital. To date, the firm has acquired over 20 portfolio companies in areas such as corporate consulting and training, educational technology, classroom instruction and technology services. The firm is an active investor in profitable and growing middle market companies where in partnership with the management, Renovus seeks to create shareholder value through operational improvements, organic growth initiatives and strategic acquisitions.
More information can be found at www.renovuscapital.com.